Nanotechnology in Medicine (Awareness Level)

A nanometre is one billionth of a metre. At this size, materials can behave differently from the same material at ordinary size.

• 1 metre = 1,000,000,000 nanometres. A human hair is about 80,000 nm wide, a red blood cell about 7,000 nm, a virus about 100 nm, a DNA strand about 2 nm.
• Small particles have a large surface compared with their volume, so they react faster and interact with cells differently.
• Gold particles look red or purple in liquid, not yellow, because of how light interacts with them.
• Nano does not mean magic; it means a size range with new properties to test and control.

Activity. Build a size chart from a metre to an atom with at least eight objects and their sizes in nanometres.

Standard to meet. Check that all sizes are within the correct order of magnitude and label the chart with units.

Nanoparticles can make signals clearer or detect small amounts of a marker in a sample.

• Contrast agents improve scan images in some tests.
• Test strips use nanoparticles to make a line visible, and sensors can detect very small amounts of a substance.
• False positives and false negatives still occur, so results must be confirmed when they matter.
• Always follow instructions and storage conditions of a test.

Activity. Explain a test strip to a peer in your own words using a drawing.

Standard to meet. Confirm that a peer can repeat how the line forms and one limit of the test.

Carriers can protect a drug and help it reach where it is needed.

• Lipid (fat-based) particles protect fragile genetic medicines during delivery.
• Targeting aims to put drug where it is needed and reduce side effects elsewhere.
• Particles can be cleared by the liver and kidneys or trigger immune reactions.
• Each carrier is tested for size, stability, safety and release.

Activity. Draw a delivery diagram labelling carrier, drug, target and clearance route.

Standard to meet. Diagram labels all four and has no false claims.

Size, shape and surface decide where particles go and how long they stay.

• Very small particles may pass through kidneys; larger ones are caught by the liver and spleen.
• Surface coatings change how the immune system sees them.
• Long-term build-up is a concern for some materials.
• Animal-free and human-cell methods help early safety testing where possible.

Activity. Build a table of size, likely route and a concern for three particle types.

Standard to meet. Check that entries agree with the sources you cite.

Nanomedicines go through extra checks because size and surface strongly affect behaviour.

• Path: lab studies, safety testing, human trials, regulator review, approval, monitoring after sale.
• Regulators ask for particle size distribution, stability, purity and batch consistency.
• Manufacturing changes can change behaviour, so they are controlled.
• Report side effects to the national system.

Activity. Map the path from lab to patient with at least six stages and one check at each.

Standard to meet. Include all stages and make the checks specific.

An honest briefing lists uncertainty as clearly as benefit.

• Possible concerns: inflammation, accumulation, allergy, effects over many years.
• Environmental release during making and disposal needs control.
• Workers handling powders need closed systems and protective equipment.
• State what is not yet known.

Activity. List five risks, a control for each and one unknown.

Standard to meet. Give each risk a control and state the unknown honestly.

News often reports lab results as if they were cures.

• Stage check: idea, lab or cell study, animal study, human trial, approved.
• Be wary of "miracle" words and of results in a single small study.
• Look for independent reviews and trial registry entries.
• Ask who funded the work.

Activity. Review three real headlines and assign each an evidence stage.

Standard to meet. Justify each stage with a quote.

Combine facts, benefits, risks and fairness.

• Cover three uses with benefits, risks and stage.
• Add access and cost questions.
• State what is unknown.
• Test with a non-expert.

Activity. Write and present a two-page briefing.

Standard to meet. Confirm that the reader repeats three limits correctly.

L1: learner can say what nano means. Focus module: The nanoscale (Understand, 2 h). A nanometre is one billionth of a metre. At this size, materials can behave differently from the same material at ordinary size. Key points: 1 metre = 1,000,000,000 nanometres. A human hair is about 80,000 nm wide, a red blood cell about 7,000 nm, a virus about 100 nm, a DNA strand about 2 nm. Small particles have a large surface compared with their volume, so they react faster and interact with cells differently. Gold particles look red or purple in liquid, not yellow, because of how light interacts with them. Nano does not mean magic; it means a size range with new properties to test and control.

Speaker notes. Teach: open with the worked example. A gold nanoparticle 20 nm wide is about 4,000 times narrower than a hair. A rapid test strip uses such particles to show a coloured line when a marker is present. Then set the activity: Build a size chart from a metre to an atom with at least eight objects and their sizes in nanometres. Mark against the standard: Check that all sizes are within the correct order of magnitude and label the chart with units. Check at this level: How many nanometres in a metre? Model answer: 1,000,000,000.

L2: learner can name medical uses. Focus module: Imaging and diagnostics (Understand, 2 h). Nanoparticles can make signals clearer or detect small amounts of a marker in a sample. Key points: Contrast agents improve scan images in some tests. Test strips use nanoparticles to make a line visible, and sensors can detect very small amounts of a substance. False positives and false negatives still occur, so results must be confirmed when they matter. Always follow instructions and storage conditions of a test.

Speaker notes. Teach: open with the worked example. A pregnancy test strip uses coloured nanoparticles attached to antibodies. They gather at the test line only if the hormone is present, giving a visible line. Then set the activity: Explain a test strip to a peer in your own words using a drawing. Mark against the standard: Confirm that a peer can repeat how the line forms and one limit of the test. Check at this level: Name a medical use. Model answer: Imaging, test strips or drug delivery.

L3: learner can read size charts. Focus module: Drug delivery (Understand, 3 h). Carriers can protect a drug and help it reach where it is needed. Key points: Lipid (fat-based) particles protect fragile genetic medicines during delivery. Targeting aims to put drug where it is needed and reduce side effects elsewhere. Particles can be cleared by the liver and kidneys or trigger immune reactions. Each carrier is tested for size, stability, safety and release.

Speaker notes. Teach: open with the worked example. Some vaccines use fat-based particles around genetic instructions so that they survive until they reach cells, then release their cargo. Then set the activity: Draw a delivery diagram labelling carrier, drug, target and clearance route. Mark against the standard: Diagram labels all four and has no false claims. Check at this level: What does a drug carrier do? Model answer: It protects the drug and helps it reach where it is needed.

L4: learner can explain delivery and clearance. Focus module: Particles in the body (Analyse, 3 h). Size, shape and surface decide where particles go and how long they stay. Key points: Very small particles may pass through kidneys; larger ones are caught by the liver and spleen. Surface coatings change how the immune system sees them. Long-term build-up is a concern for some materials. Animal-free and human-cell methods help early safety testing where possible.

Speaker notes. Teach: open with the worked example. Studies often report particles around 100 nm circulating longer than particles of 500 nm, which are filtered quickly. Then set the activity: Build a table of size, likely route and a concern for three particle types. Mark against the standard: Entries agree with the sources you cite. Check at this level: Why does size matter in the body? Model answer: It decides where particles go and how they clear.

L5: learner can review claims and regulation. Focus module: Testing and regulation (Evaluate, 3 h). Nanomedicines go through extra checks because size and surface strongly affect behaviour. Key points: Path: lab studies, safety testing, human trials, regulator review, approval, monitoring after sale. Regulators ask for particle size distribution, stability, purity and batch consistency. Manufacturing changes can change behaviour, so they are controlled. Report side effects to the national system.

Speaker notes. Teach: open with the worked example. A batch is rejected because particle size varied beyond the allowed range. The factory fixes mixing time and re-tests before release. Then set the activity: Map the path from lab to patient with at least six stages and one check at each. Mark against the standard: All stages present; checks are specific. Check at this level: What do regulators check? Model answer: Size distribution, stability and safety.

L6: learner can coordinate a lab file. Focus module: Hype, claims and headlines (Analyse, 2 h). News often reports lab results as if they were cures. Key points: Stage check: idea, lab, animal-free or animal study, human trial, approved. Be wary of "miracle" words and of results in a single small study. Look for independent reviews and trial registry entries. Ask who funded the work.

Speaker notes. Teach: open with the worked example. A headline says tiny particles "destroy cancer". The study is in cells in a dish. The learner labels it "lab stage, not a treatment". Then set the activity: Review three real headlines and assign each an evidence stage. Mark against the standard: Each stage is justified with a quote. Check at this level: How judge a headline? Model answer: Find the evidence stage.

L7: learner can audit a briefing. Focus module: Write the balanced briefing (Create, 3 h). Combine facts, benefits, risks and fairness. Key points: Cover three uses with benefits, risks and stage. Add access and cost questions. State what is unknown. Test with a non-expert.

Speaker notes. Teach: open with the worked example. The reader can explain why approval takes years and why one lab result is not enough. Then set the activity: Write and present a two-page briefing. Mark against the standard: Reader repeats three limits correctly. Check at this level: Who gets access? Model answer: A fairness question to state.